To the Point

Clinical Pearls for Autologous Serum Drops

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, welcome Alfonso L. Sabater, MD, PhD, on this episode of To the Point to share his expertise on the use of autologous serum drops in the treatment of ocular surface and corneal disease. Dr. Sabater describes some of the clinical benefits and challenges, which patients may be ideal candidates, and what clinicians should know when getting started with this treatment option.

Aesthetics and the Ocular Surface

Tracy Doll, OD, FAAO, joins co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, on this episode of To the Point to share her expertise with the aesthetics side of managing ocular surface disease. Dr. Doll discusses her experiences addressing patients’ clinical and aesthetic concerns, educating patients and other providers on the cosmetic benefits of certain dry eye therapies, integrating new innovations in her clinic, and more.

Running a Standalone Dry Eye Clinic

To the Point co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, sit down with Jason Besecker, OD, MS, to get his perspective on opening a dry eye only clinic. Dr. Besecker shares how he became interested in treating dry eye patients exclusively, growing his referral base after opening his practice, maintaining profitability without an optical shop, technology and diagnostics he has incorporated over the years, and more.

Building Out a Dry Eye and Aesthetics Practice

This month on To the Point, Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, invite Shane Swatts, OD, to join them on the podcast to share tips from his experience growing a dry eye and ocular aesthetics practice. He talks about integrating cutting-edge technology, gives advice on discussing advanced treatment options with patients, suggests how to set actionable treatment goals, and more.

Takeways From the TFOS DEWS III Report

In this episode of To the Point, Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, get into a deep discussion with Vin T. Dang, OD, FAAO, on the recent Tear Film & Ocular Surface Society Dry Eye Workshop (TFOS DEWS) III Report. Dr. Dang shares his top takesaways from the report and offers his thoughts on a recently FDA-approved neuromodulating agent that treats dry eye by stimulating increased tear production.